IMMX — Immix Biopharma, Inc. stock price, charts and financials

QT92Immix Biopharma, Inc.

Immix Biopharma, Inc. (NASDAQ: IMMX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.50
-0.22-1.73%
OverviewShort InterestFilings
IMMXQT92Immix Biopharma, Inc.·NASDAQ
12.50-1.73%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 202610-QQuarterly report
Jul 20, 20268-KCurrent report
Jun 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 21, 2026424B5Prospectus
May 21, 20268-KCurrent report
May 21, 2026FWPFree writing prospectus
May 21, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 06, 2026DEF 14ADefinitive proxy statement
Apr 06, 2026ARSAnnual report to shareholders
Apr 06, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 232
Page
▼
/ 10